Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 5 of 5 descriptions
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Bladder instillation WITH triamcinolone acetonide | [1] Triamcinolone Triamcinolone (Triamcinolone Acetonide Nasal) | [1] Triamcinolone
Triamcinolone
💬1. Bladder instillation WITH triamcinolone acetonide
| [1] NR3C1 NR3C1 💬1. Bladder instillation WITH triamcinolone acetonide
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 226 226 💬1. Bladder instillation WITH triamcinolone acetonide
| ||||||||||||||||
| 2 | Bladder instillation WITHOUT triamcinolone acetonide | [1] Triamcinolone Triamcinolone (Triamcinolone Acetonide Nasal) | [1] Triamcinolone
Triamcinolone
💬2. Bladder instillation WITHOUT triamcinolone acetonide
| [1] NR3C1 NR3C1 💬2. Bladder instillation WITHOUT triamcinolone acetonide
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 226 226 💬2. Bladder instillation WITHOUT triamcinolone acetonide
| ||||||||||||||||
| 3 | Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonidefollowed the systemic combi ... | [5] Dapsone Dapsone,Mycophenolate mofetil, Mycophenolic acid, Prednisolone, Triamcinolone (Triamcinolone Acetonide Nasal) [5] Dapsone, Mycophenolate mofetil, Mycophenolic acid, Prednisolone, Triamcinolone(Triamcinolone Acetoni ... | [5] Triamcinolone
Triamcinolone
,Prednisolone , Dapsone , Mycophenolate mofetil , Mycophenolic acid 💬 [5] Triamcinolone , Prednisolone , Dapsone , Mycophenolate mofetil , Mycophenolic acid 💬 ... 3. Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP
| [3] IMPDH1 IMPDH1,IMPDH2, NR3C1 💬 3. Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP | [5] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬 [5] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nu ... | [1] 162 162 💬3. Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP
| ||||||||||||||||
| 4 | Triamcinolone Acetonide | [1] Triamcinolone Triamcinolone (Triamcinolone Acetonide Nasal) | [1] Triamcinolone
Triamcinolone
💬4. Triamcinolone Acetonide
| [1] NR3C1 NR3C1 💬4. Triamcinolone Acetonide
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 35 35, 46, 56 💬
| ||||||||||||||||
| 5 | Triamcinolone Acetonide and normal saline solution | [1] Triamcinolone Triamcinolone (Triamcinolone Acetonide Nasal) | [1] Triamcinolone
Triamcinolone
💬5. Triamcinolone Acetonide and normal saline solution
| [1] NR3C1 NR3C1 💬5. Triamcinolone Acetonide and normal saline solution
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 70 70 💬5. Triamcinolone Acetonide and normal saline solution
|